Back
iRadimed Vs. REV Group Industry Stock Comparison
Sell
41
IRMD
iRadimed
Last Price:
$55.61
Seasonality Move:
-0.05%
Buy
66
REVG
REV Group
Last Price:
$33.87
Seasonality Move:
10.26%
Sell
41
iRadimed (IRMD)
is a Sell
Is iRadimed a Buy, Sell or Hold?
-
IRMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IRMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 59.4 | Buy |
Chaikin Money Flow: | 17717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.39 - 55.07) | Buy |
Bollinger Bands (100): | (47.09 - 54.21) | Buy |
REVG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.45 | Buy |
Relative Strength Index (14 RSI): | 62.04 | Buy |
Chaikin Money Flow: | 457314 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.58 - 33.28) | Buy |
Bollinger Bands (100): | (27.16 - 31.44) | Buy |
IRMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.81 | Buy |
20-day SMA: | 54.3 | Buy |
50-day SMA: | 53.5 | Buy |
200-day SMA: | 47.03 | Buy |
8-day EMA: | 54.84 | Buy |
20-day EMA: | 54.34 | Buy |
50-day EMA: | 53.19 | Buy |
200-day EMA: | 48.6 | Buy |
REVG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.81 | Buy |
20-day SMA: | 32.06 | Buy |
50-day SMA: | 30.41 | Buy |
200-day SMA: | 26.99 | Buy |
8-day EMA: | 32.23 | Buy |
20-day EMA: | 31.89 | Buy |
50-day EMA: | 30.8 | Buy |
200-day EMA: | 26.83 | Buy |
iRadimed Earnings Growth & IRMD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.40 per share.
REV Group Earnings Growth & REVG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.17 per share, an increase this year of $0.71 per share, and an increase next year of $0.73 per share.
iRadimed Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
REV Group Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |